Rapid intrapartum test (Strep B OIA) and prenatal cultures for identification of group B streptococcal carriers at delivery: a prospective study

in AAmerican Society of Microbiology (Ed.) Program and Abstracts of the 40th Intersciences Conference on Antimicrobial Agents and Chemotherapy (2000, September)

Background: The efficacy of the prenatal screening-based approach recommended by the CDC to prevent neonatal GBS diseases could be improved by using a good rapid test performed at the onset of labor. To ... [more ▼]

Background: The efficacy of the prenatal screening-based approach recommended by the CDC to prevent neonatal GBS diseases could be improved by using a good rapid test performed at the onset of labor. To assess the Strep B OIA® test (Biostar, Boulder, Co), completed in 30 minutes, we initiated a 6-center study to compare it with prenatal screening cultures to identify GBS carriers at delivery or opportunities to initiate intrapartum antibioprophylaxis (IAP). Methods: For a total of 539 pregnant women included in the study, pairs of vaginal/anal specimens collected at 35-37 weeks and intrapartum vaginal specimens were plated onto colistin-nalidixic agar and then inoculated into selective LIM broth for the detection of GBS. Furthermore, on each intrapartum vaginal swab a Strep B OIA test was performed. Results: GBS were recovered in culture from 89 prenatal screenings (17%) and from 71 specimens collected at delivery (13%). Strep B OIA test identified 48 positive specimens (9%). Respectively, for the identification of GBS carriers at delivery, sensitivity, specificity, positive and negative predictive values for prenatal screening cultures were 69%, 91%, 55% and 95% and for Strep B OIA tests they were 63%, 99%, 94% and 95%. Evaluating opportunities to start an IAP, based on Strep OIA test versus prenatal screening cultures, 45 IAP vs. 49 would have been useful, 3 vs. 40 useless (P< 0,001) and 26 vs. 22 missed. Conclusion: To identify GBS carriers, the Strep B OIA test, performed at the time of onset of labor is equally sensitive to prenatal screening cultures and would allow a highly significant reduction of useless IAP. [less ▲]

Streptocoques du groupe B: premier agent responsable d'infections néonatales graves. Epidémiologie, facteurs de risque, prévention et technique de dépistage.

Conference (2000, August 30)

Gravité de l'infection néonatale à GBS. Stratégies de prévention et Prise en charge du nouveau-né. Situation en Communauté Française.

Conference (2000, May 06)

Place des examens d'urine dans la biologie clinique actuelle

Conference (2000, February 10)

Streptococcus agalactiae (dans rapport de surveillance des maladies infectieuses 1999)

Report (2000)

Comment j'explore...une mycobactériose cutanée atypique

in Revue Médicale de Liège (2000), 55(12), 1058-1063

Atypical mycobacteriosis affecting the skin are diverse and their treatments are different as well. These diseases show an increasing prevalence. The contamination occurs from the environment while ... [more ▼]

Atypical mycobacteriosis affecting the skin are diverse and their treatments are different as well. These diseases show an increasing prevalence. The contamination occurs from the environment while interhuman transmission does not occur. [less ▲]

Serotype Distribution of Invasive Streptococcus agalactiae Isolated from Neonates and Adults in Belgium over a 4-years Period (1995-1999)

Poster (1999, October)

Surveillance of antimicrobial resistance in Streptococcus agalactiae isolated from patients in Belgium (1989-1991 versus 1996-1999)

Poster (1999, September)

Epidemiological Typing of Extended-Spectrum Beta-Lactamase-Producing Klebsiella Pneumoniae Isolates by Pulsed-Field Gel Electrophoresis and Antibiotic Susceptibility Patterns

in Research in Microbiology (1999), 150(4), 265-72

Over a 16-month period, Klebsiella pneumoniae isolates from 102 patients admitted to a university hospital in Liege (Belgium) produced extended-spectrum beta-lactamases. Pulsed-field gel electrophoresis ... [more ▼]

Over a 16-month period, Klebsiella pneumoniae isolates from 102 patients admitted to a university hospital in Liege (Belgium) produced extended-spectrum beta-lactamases. Pulsed-field gel electrophoresis of genome macrorestriction patterns with XbaI and antibiotic susceptibility patterns subdivided 39 isolates into eight clonally related groups. Two of them were implicated in the course of this outbreak. They were responsible for successive waves of infection or colonization in different wards of the hospital while the others were encountered sporadically. A beta-lactamase with an isoelectric point of 7.6 and consistent with type SHV-2 characterized all nine isolates chosen among both major groups. [less ▲]

Comparative evaluation of Fungitest, Neosensitabs and broth microdilution method for yeasts susceptibility testing

Poster (1999, May)

The need of a simple and reliable method for routine yeasts susceptibility testing led us to evaluate two commercially available methods. We investigated the in vitro susceptibility of 67 clinical ... [more ▼]

The need of a simple and reliable method for routine yeasts susceptibility testing led us to evaluate two commercially available methods. We investigated the in vitro susceptibility of 67 clinical isolates (26 C. albicans, 32 C. glabrata, 4 C. krusei, 2 C. tropicalis, 2 C. kefyr and 1 S. cerevisiae) to 6 drugs flucytosine (FC), amphotericin B (A), fluconazole (FZ), itraconazole (IT), kétoconazole (K), miconazole (M), comparing two methods Fungitest (Sanofi Pasteur) and Neosensitabs (Rosco). A broth microdilution adaptation from the NCCLS-M27A procedure was used as reference method. Fungitests consist of individually packed 16 wells microplates containing 6 drugs at two critical concentrations in buffered medium. Reading was performed after 24 and 48h incubation. Neosensitabs is an agar diffusion method on Shadomy agar using antifungals tablets. Reading was performed after 24h. For all strains Neosensitabs was in concordance with NCCLS M27-A for FC (94%), A (98%), FZ (55%) I (53%) with p<0.05. Fungitest correlated with NCCLS method for all antifungals after 24 and 48h incubation time (p<0.05) with respectively 95/95% for FC, 100/100% for A, 80/76% for FZ, 81/55% for I and 93/75% for K, and 88/81 for M. Candida glabrata gave the poorest result with Neosensitabs with 28% concordance for FZand 39% for I; therefore the method can't be recommended for this species. Fungitest concordance observed was 55% for I after 48h. Our results suggest that Fungitest is appropriate for routine yeast susceptibility testing. However itraconazole testing has to be improved with this method. [less ▲]